NICOLE GIARDINO: Open Payments
NPI 1376961292 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,319 in 51 payments from 11 companies in 2025. Trend: 2023 $1,411 · 2024 $1,063 · 2025 $1,319
Food & beverage: $1,319
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $422 |
| GENZYME CORPORATION | 7 | $263 |
| ABBVIE INC. | 9 | $240 |
| Novartis Pharmaceuticals Corporation | 8 | $172 |
| Amgen Inc. | 2 | $61 |
| STRATA Skin Sciences, Inc. | 5 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
| PFIZER INC. | 1 | $29 |
| Botanix SB Inc | 1 | $25 |
| UCB, Inc. | 1 | $15 |
Products named: TREMFYA, DUPIXENT, BOTOX, COSENTYX, OTEZLA, XTRAC, SPEVIGO, CIBINQO.
Industry payments across MA — which companies pay providers there.
